Log In
Print
BCIQ
Print
Print this Print this
 

SD-809

  Manage Alerts
Collapse Summary General Information
Company Auspex Pharmaceuticals Inc.
DescriptionDeuterium-substituted analog of tetrabenazine, a vesicular monoamine transporter 2 (VMAT2; SLC18A2) inhibitor
Molecular Target Vesicular monoamine transporter 2 (VMAT2) (SLC18A2)
Mechanism of ActionVesicular monoamine transporter 2 inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard IndicationHuntington's disease (HD)
Indication DetailsTreat chorea associated with Huntington's disease (HD); Treat Huntington's disease (HD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today